This article has Open Peer Review reports available.
The GOLMePsA study protocol: an investigator-initiated, double-blind, parallel-group, randomised, controlled trial of GOLimumab and methotrexate versus methotrexate in early diagnosed psoriatic arthritis using clinical and whole body MRI outcomes
© The Author(s). 2017
Received: 13 December 2016
Accepted: 5 July 2017
Published: 18 July 2017
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting firstname.lastname@example.org.
|13 Dec 2016||Submitted||Original manuscript|
|28 Feb 2017||Reviewed||Reviewer Report - Julien Paccou|
|22 Jun 2017||Reviewed||Reviewer Report - René Poggenborg|
|29 Jun 2017||Author responded||Author comments - Gabriele De Marco|
|Resubmission - Version 2|
|29 Jun 2017||Submitted||Manuscript version 2|
|4 Jul 2017||Author responded||Author comments - Gabriele De Marco|
|Resubmission - Version 3|
|4 Jul 2017||Submitted||Manuscript version 3|
|5 Jul 2017||Editorially accepted|
|18 Jul 2017||Article published||10.1186/s12891-017-1659-1|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting email@example.com. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.